To access the full text documents, please follow this link: http://hdl.handle.net/2445/136714
dc.contributor.author | Carugati, Manuela |
---|---|
dc.contributor.author | Aliberti, Stefano |
dc.contributor.author | Reyes, Luis F. |
dc.contributor.author | Franco Sadud, Ricardo |
dc.contributor.author | Irfan, Muhammad |
dc.contributor.author | Prat, Cristina |
dc.contributor.author | Soni, Nilam J. |
dc.contributor.author | Faverio, Paola |
dc.contributor.author | Gori, Andrea |
dc.contributor.author | Blasi, Francesco |
dc.contributor.author | Restrepo, Marcos I. |
dc.contributor.author | Cillóniz, Catia |
dc.contributor.author | Torres Martí, Antoni |
dc.contributor.author | GLIMP collaborators |
dc.date | 2019-07-09T11:12:12Z |
dc.date | 2019-07-09T11:12:12Z |
dc.date | 2018-10-04 |
dc.date | 2019-07-02T19:44:26Z |
dc.identifier | 2312-0541 |
dc.identifier | 5635448 |
dc.identifier | 30474036 |
dc.identifier.uri | http://hdl.handle.net/2445/136714 |
dc.description | This study aimed to describe real-life microbiological testing of adults hospitalised with community-acquired pneumonia (CAP) and to assess concordance with the 2007 Infectious Diseases Society of America (IDSA)/American Thoracic Society (ATS) and 2011 European Respiratory Society (ERS) CAP guidelines. This was a cohort study based on the Global Initiative for Methicillin-resistant Staphylococcus aureus Pneumonia (GLIMP) database, which contains point-prevalence data on adults hospitalised with CAP across 54 countries during 2015. In total, 3702 patients were included. Testing was performed in 3217 patients, and included blood culture (71.1%), sputum culture (61.8%), Legionella urinary antigen test (30.1%), pneumococcal urinary antigen test (30.0%), viral testing (14.9%), acute-phase serology (8.8%), bronchoalveolar lavage culture (8.4%) and pleural fluid culture (3.2%). A pathogen was detected in 1173 (36.5%) patients. Testing attitudes varied significantly according to geography and disease severity. Testing was concordant with IDSA/ATS and ERS guidelines in 16.7% and 23.9% of patients, respectively. IDSA/ATS concordance was higher in Europe than in North America (21.5% versus 9.8%; p<0.01), while ERS concordance was higher in North America than in Europe (33.5% versus 19.5%; p<0.01). Testing practices of adults hospitalised with CAP varied significantly by geography and disease severity. There was a wide discordance between real-life testing practices and IDSA/ATS/ERS guideline recommendations. |
dc.format | 13 p. |
dc.format | application/pdf |
dc.language | eng |
dc.publisher | European Respiratory Society |
dc.relation | Reproducció del document publicat a: https://doi.org/10.1183/23120541.00096-2018 |
dc.relation | ERJ Open Research, 2018, vol. 4, num. 4 |
dc.relation | https://doi.org/10.1183/23120541.00096-2018 |
dc.rights | cc by-nc (c) ERS, 2018 |
dc.rights | http://creativecommons.org/licenses/by-nc/3.0/es/ |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Pneumònia adquirida a la comunitat |
dc.subject | Microbiologia mèdica |
dc.subject | Community-acquired pneumonia |
dc.subject | Medical microbiology |
dc.title | Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |